Horváth, Luděk http://orcid.org/0000-0001-7873-0159
Mráz, Miloš http://orcid.org/0000-0001-5322-4612
Jude, Edward B. http://orcid.org/0000-0002-3186-4122
Haluzík, Martin http://orcid.org/0000-0002-0201-6888
Article History
Accepted: 25 March 2024
First Online: 6 July 2024
Declarations
:
: Open access publishing supported by the National Technical Library in Prague. This work was supported by the National Institute for Research on Metabolic and Cardiovascular Diseases project (EXCELES Program; ID: LX22NPO5104), funded by the European Union—Next Generation EU.
: Luděk Horváth and Miloš Mráz have no conflicts of interest to declare in relation to this work. Edward B. Jude has received research grants, speaker fees, and travel grants from Novo Nordisk, Eli Lilly, Sanofi, Menarini and Astra Zeneca. Martin Haluzík participated in Advisory Boards for Novo Nordisk, Eli Lilly, Sanofi, Merck, and Pfizer, and received research support from Sanofi and consulting and speaker fees from Sanofi and Novo Nordisk.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: LH, EBJ, MH. Writing: LH. Review and editing: MM, EBJ, MH. Funding acquisition: MH. All authors read, critically revised, and approved the final manuscript.